glp 1 drug liraglutide may protect against dementia Could GLP‑1 Weight‑Loss Drugs Help Tackle Alzheimer's Disease? Alzheiemer's: Can a GLP-1 drug

Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)

The most striking protective effects of SGLT2is were a marked reduction in hospitalization for heart failure and a remarkable reduced progression of chronic kidney disease

Indias pharma industry is strong

This update elevates obesity within the global noncommunicable disease agenda and sets a clear mandate for action

Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.

Learn about the mechanism of action of RYBELSUS (semaglutide) for your adult patients with type 2 diabetes